Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Exon Array Biomarkers for the Differential Diagnosis of Schizophrenia and Bipolar Disorder.

Vawter MP, Philibert R, Rollins B, Ruppel PL, Osborn TW.

Mol Neuropsychiatry. 2018 May;3(4):197-213. doi: 10.1159/000485800. Epub 2018 Apr 10.

2.

Prescription of potentially inappropriate psychotropic drugs in homeless people with schizophrenia and bipolar disorders. Results from the French Housing First (FHF) program.

Fond G, Tinland A, Boucekine M, Girard V, Loubière S, Auquier P, Boyer L; French Housing First Study Group.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:84-89. doi: 10.1016/j.pnpbp.2018.08.024. Epub 2018 Aug 25.

PMID:
30153497
3.

Discovery and validation of blood biomarkers for suicidality.

Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N, Winiger E, Bhosrekar S, Shankar G, Radel M, Bellanger E, Duckworth H, Olesek K, Vergo J, Schweitzer R, Yard M, Ballew A, Shekhar A, Sandusky GE, Schork NJ, Kurian SM, Salomon DR, Niculescu AB 3rd.

Mol Psychiatry. 2013 Dec;18(12):1249-64. doi: 10.1038/mp.2013.95. Epub 2013 Aug 20.

4.

Utilization of never-medicated bipolar disorder patients towards development and validation of a peripheral biomarker profile.

Clelland CL, Read LL, Panek LJ, Nadrich RH, Bancroft C, Clelland JD.

PLoS One. 2013 Jun 24;8(6):e69082. doi: 10.1371/journal.pone.0069082. Print 2013.

5.

Towards a blood-based diagnostic panel for bipolar disorder.

Haenisch F, Cooper JD, Reif A, Kittel-Schneider S, Steiner J, Leweke FM, Rothermundt M, van Beveren NJM, Crespo-Facorro B, Niebuhr DW, Cowan DN, Weber NS, Yolken RH, Penninx BWJH, Bahn S.

Brain Behav Immun. 2016 Feb;52:49-57. doi: 10.1016/j.bbi.2015.10.001. Epub 2015 Oct 13.

6.

Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders.

Morgan LZ, Rollins B, Sequeira A, Byerley W, DeLisi LE, Schatzberg AF, Barchas JD, Myers RM, Watson SJ, Akil H, Bunney WE Jr, Vawter MP.

Microarrays (Basel). 2016 Mar;5(1). pii: 6. Epub 2016 Mar 7.

7.

Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis.

Kageyama Y, Kasahara T, Morishita H, Mataga N, Deguchi Y, Tani M, Kuroda K, Hattori K, Yoshida S, Inoue K, Kato T.

Psychiatry Clin Neurosci. 2017 Feb;71(2):115-123. doi: 10.1111/pcn.12461. Epub 2016 Nov 16. Erratum in: Psychiatry Clin Neurosci. 2017 May;71(5):346.

8.

The Electroretinogram May Differentiate Schizophrenia From Bipolar Disorder.

Hébert M, Mérette C, Gagné AM, Paccalet T, Moreau I, Lavoie J, Maziade M.

Biol Psychiatry. 2020 Feb 1;87(3):263-270. doi: 10.1016/j.biopsych.2019.06.014. Epub 2019 Jun 27.

PMID:
31443935
9.

Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.

Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N, Belanger E, James A, George S, Weber H, Graham DL, Schweitzer R, Ladd TB, Learman R, Niculescu EM, Vanipenta NP, Khan FN, Mullen J, Shankar G, Cook S, Humbert C, Ballew A, Yard M, Gelbart T, Shekhar A, Schork NJ, Kurian SM, Sandusky GE, Salomon DR.

Mol Psychiatry. 2015 Nov;20(11):1266-85. doi: 10.1038/mp.2015.112. Epub 2015 Aug 18.

10.

Shared gene expression alterations in schizophrenia and bipolar disorder.

Shao L, Vawter MP.

Biol Psychiatry. 2008 Jul 15;64(2):89-97. doi: 10.1016/j.biopsych.2007.11.010. Epub 2008 Jan 11.

11.

Verbal episodic memory along the course of schizophrenia and bipolar disorder: a new perspective.

Czepielewski LS, Massuda R, Goi P, Sulzbach-Vianna M, Reckziegel R, Costanzi M, Kapczinski F, Rosa AR, Gama CS.

Eur Neuropsychopharmacol. 2015 Feb;25(2):169-75. doi: 10.1016/j.euroneuro.2014.09.006. Epub 2014 Sep 16.

PMID:
25311898
12.

Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2010;10(21):1-111. Epub 2010 Dec 1.

13.

Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis.

Girshkin L, Matheson SL, Shepherd AM, Green MJ.

Psychoneuroendocrinology. 2014 Nov;49:187-206. doi: 10.1016/j.psyneuen.2014.07.013. Epub 2014 Jul 21.

PMID:
25108162
14.

The impact of familial risk for schizophrenia or bipolar disorder on cognitive control during episodic memory retrieval.

Christodoulou T, Messinis L, Papathanasopoulos P, Frangou S.

Psychiatry Res. 2012 May 30;197(3):212-6. doi: 10.1016/j.psychres.2011.12.028. Epub 2012 Mar 13.

PMID:
22417935
15.

Neuroimaging-aided differential diagnosis of the depressive state.

Takizawa R, Fukuda M, Kawasaki S, Kasai K, Mimura M, Pu S, Noda T, Niwa S, Okazaki Y; Joint Project for Psychiatric Application of Near-Infrared Spectroscopy (JPSY-NIRS) Group.

Neuroimage. 2014 Jan 15;85 Pt 1:498-507. doi: 10.1016/j.neuroimage.2013.05.126. Epub 2013 Jun 10. Erratum in: Neuroimage. 2015 Apr 1;109:530.

PMID:
23764293
16.

[Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].

Konstantakopoulos G, Ioannidi N, Patrikelis P, Soumani A, Oulis P, Sakkas D, Papadimitriou GN, Ploumpidis D.

Psychiatriki. 2011 Jul-Sep;22(3):195-206. Greek, Modern.

PMID:
21971195
17.

Preceding diagnoses to young adult bipolar disorder and schizophrenia in a nationwide study.

Andersen SM, Randers A, Jensen CM, Bisgaard C, Steinhausen HC.

BMC Psychiatry. 2013 Dec 21;13:343. doi: 10.1186/1471-244X-13-343.

18.

Microtubule organization and L-type voltage-activated calcium current in olfactory neuronal cells obtained from patients with schizophrenia and bipolar disorder.

Solís-Chagoyán H, Calixto E, Figueroa A, Montaño LM, Berlanga C, Rodríguez-Verdugo MS, Romo F, Jiménez M, Gurrola CZ, Riquelme A, Benítez-King G.

Schizophr Res. 2013 Feb;143(2-3):384-9. doi: 10.1016/j.schres.2012.11.035. Epub 2013 Jan 3.

PMID:
23290267
19.

Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study.

Fond G, Boyer L, Gaman A, Laouamri H, Attiba D, Richard JR, Delavest M, Houenou J, Le Corvoisier P, Charron D, Krishnamoorthy R, Oliveira J, Tamouza R, Yolken R, Dickerson F, Leboyer M, Hamdani N.

J Psychiatr Res. 2015 Apr;63:58-64. doi: 10.1016/j.jpsychires.2015.02.011. Epub 2015 Feb 24.

PMID:
25769398
20.

Distinguishing medication-free subjects with unipolar disorder from subjects with bipolar disorder: state matters.

Rive MM, Redlich R, Schmaal L, Marquand AF, Dannlowski U, Grotegerd D, Veltman DJ, Schene AH, Ruhé HG.

Bipolar Disord. 2016 Nov;18(7):612-623. doi: 10.1111/bdi.12446. Epub 2016 Nov 5.

PMID:
27870505

Supplemental Content

Support Center